Celgene Sells $8 Billion of Bonds to Help Finance Receptos Deal

Updated on

Celgene Corp. sold $8 billion of bonds in five parts Monday to help finance its $7.2 billion takeover of Receptos Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.